|4Jun 11, 7:54 PM ET

Ber Gerard 4

4 · Y-mAbs Therapeutics, Inc. · Filed Jun 11, 2024

Insider Transaction Report

Form 4
Period: 2024-06-10
Ber Gerard
Director
Transactions
  • Sale

    Common Stock

    2024-06-10$12.00/sh722$8,6641,608 total
Footnotes (2)
  • [F1]Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.
  • [F2]This transaction was executed in multiple trades at prices ranging from $12.00 to $12.015, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    tm2417022-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT